stock

AbbVie, Inc. (ABBV)

0
September 3rd, 2020

Share

Stay up to date

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Financial Statements

Key Info

  • Industry: Pharmaceuticals: Major
  • Sector: Health Technology
  • CEO Name: Richard A. Gonzalez

Key Statistics

  • Stock Price: $93.95
  • Dividend Yield: 4.9%
  • Market Capitalization: $165,805,778,500
  • Shares Outstanding: 1,764,830,000
  • Number of Employees: 30,000
  • Trailing 12-Month EPS: $4.71
  • Trailing 12-Month DPS: $4.61
  • Payout Ratio: 97.89999999999999%

Important Dates

  • Next Earnings Date: 2020-10-30
  • Next Ex-Dividend Date: 2020-07-14

Price Trends

  • Current Stock Price: $93.95
  • 52-week high: $101.28
  • 52-week low: $62.55
  • 200-day moving average: $89
  • 50-day moving average: $96.27

Performance

  • 1-Month Price Return: -2.1%
  • 3-Month Price Return: 3.4%
  • 6-Month Price Return: 7.3%
  • 1-Year Price Return: 43.7%
  • 2-Year Price Return: -0.2%
  • 5-Year Price Return: 53.4%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

September 3rd, 2020